Thymidine kinase gene modified bone marrow mesenchymal stem cells as vehicles for antitumor therapy

Human Gene Therapy

Volumn 22, Issue 4, 2011, Pages 439-449

  Song, Chao ^a,b   Xiang, Juanjuan ^c   Tang, Jingqun ^d   Hirst, David G ^e   Zhou, Junwei ^a   Chan, Kai Ming ^a,f   Li, Gang ^a,f,g  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Central South University   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; GANCICLOVIR; LENTIVIRUS VECTOR; SOMATOSTATIN 14; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTITUMOR GENE; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; FIBROSARCOMA; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PROSTATE CANCER; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIVIRAL AGENTS; BONE MARROW CELLS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; GANCICLOVIR; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; LENTIVIRUS; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; THYMIDINE KINASE; TRANSGENES;

ANIMALIA; MUS MUSCULUS; SIMPLEXVIRUS;

EID: 79954490385     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.116     Document Type: Article

References (44)

1. Aboody, K.S., Bush, R.A., Garcia, E., et al. (2006). Development of a tumor-selective approach to treat metastatic cancer. PloS One 1, e23.
2. Barbash, I.M., Chouraqui, P., Baron, J., et al. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium-feasibility, cell migration, and body distribution. Circulation 108, 863-868. (Pubitemid 37022130)
3. Bianco, P., Robey, P.G., and Simmons, P.J. (2005). Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313-319.
4. Chan, J., O'Donoghue, K., De la Fuente, J., et al. (2005). Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23, 93-102. (Pubitemid 40105295)
5. Chen, C.P., Lee, M.Y., Huang, J.P., et al. (2008). Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor receptor-1 and integrins. Stem Cells 26, 550-561.
6. Chen, X., Armstrong, M.A., and Li, G. (2006a). Mesenchymal stem cells in immunoregulation. Immunol. Cell Biol. 84, 413-421. (Pubitemid 44286034)
7. Chen, X., Xu, H., Wan, C., et al. (2006b). Bioreactor expansion of human adult bone marrow-derived mesenchymal stem cells. Stem Cells 24, 2052-2059. (Pubitemid 44477130)
8. Chen, X., McClurg, A., Zhou, G.Q., et al. (2007). Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Stem Cells 25, 364-370. (Pubitemid 46232790)
9. Croitoru-Lamoury, J., Lamoury, F.M.J., Zaunders, J.J., et al. (2007). Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. J. Interferon Cytokine Res. 27, 53-64. (Pubitemid 46185062)
10. Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838-3843. (Pubitemid 34534559)
11. Dvorak, H.F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound-healing. N. Engl. J. Med. 315, 1650-1659. (Pubitemid 17052899)
12. Dwyer, R.M., Potter-Beirne, S.M., Harrington, K.A., et al. (2007). Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin. Cancer Res. 13, 5020-5027. (Pubitemid 47502066)
13. Elzaouk, L., Moelling, K., and Pavlovic, J. (2006). Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model. Exp. Dermatol. 15, 865-874. (Pubitemid 44473325)
14. Fillat, C., Carrió, M., Cascante, A., and Sangro, B. (2003). Suicide gene therapy mediated by the Herpes Simplex virus thymi-dine kinase gene/Ganciclovir system: fifteen years of application. Curr. Gene Ther. 3, 13-26.
15. Hakkarainen, T., Särkioja, M., Lehenkari, P., et al. (2007). Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors. Hum. Gene Ther. 18, 627-641. (Pubitemid 47187094)
16. Hall, B., Dembinski, J., Sasser, A.K., et al. (2007). Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int. J. Hematol. 86, 8-16. (Pubitemid 47204483)
17. Honczarenko, M., Le, Y., Swierkowski, M., et al. (2006). Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24, 1030-1041. (Pubitemid 44464736)
18. Ilsley, D.D., Lee, S.H., Miller, W.H., and Kuchta, R.D. (1995). Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action. Biochemistry 34, 2504-2510.
19. Kawada, H., Fujita, J., Kinjo, K., et al. (2004). Non-hematopoietic bone marrow cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction: Possible contribution of mesenchymal stem cells. Blood 104, 3581-3587. (Pubitemid 39564430)
20. Khakoo, A.Y., Pati, S., Anderson, S.A., et al. (2006). Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. 203, 1235-1247. (Pubitemid 43736593)
21. Kucerova, L., Altanerova, V., Matuskova, M., et al. (2007). Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 67, 6304-6313. (Pubitemid 47037513)
22. Love, Z., Wang, F., Dennis, J., et al. (2007). Imaging of mesen-chymal stem cell transplant by bioluminescence and PET. J. Nucl. Med. 48, 2011-2020. (Pubitemid 350232312)
23. Lu, Y.R., Yuan, Y., Wang, X.J., et al. (2008). The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol. Ther. 7, 245-251. (Pubitemid 351590431)
24. Marini, F., Studeny, M., and Andreeff, M. (2005). Re: Mesen-chymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents response. J. Natl. Cancer Inst. 97, 541-542.
25. Menon, L.G., Picinich, S., Koneru, R., et al. (2007). Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 25, 520-528. (Pubitemid 46232808)
26. Miletic, H., Fischer, Y., Litwak, S., et al. (2007). Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol. Ther. 15, 1373-1381. (Pubitemid 46965333)
27. Mishra, P.J., Mishra, P.J., Humeniuk, R., et al. (2008). Carcinoma-associated fibroblast-like differentiation of human mesenchy-mal stem cells. Cancer Res. 68, 4331-4339.
28. Nakamizo, A., Marini, F., Amano, T., et al. (2005). Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 65, 3307-3318. (Pubitemid 40524615)
29. O'Donoghue, K., Choolani, M., Chan, J., et al. (2003). Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol. Hum. Reprod. 9, 497-502. (Pubitemid 36874308)
30. Potian, J.A., Aviv, H., Ponzio, N.M., et al. (2003). Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 171, 3426-3434. (Pubitemid 37254543)
31. Ray, P., Tsien, R., and Gambhir, S.S. (2007). Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res. 67, 3085-3093. (Pubitemid 46724845)
32. Ringe, J., Strassburg, S., Neumann, K., et al. (2007). Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J. Cell. Biochem. 101, 135-146. (Pubitemid 46652579)
33. Sasaki, M., Abe, R., Fujita, Y., et al. (2008). Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. 180, 2581-2587.
34. Satake, K., Lou, J., and Lenke, L.G. (2004). Migration of mesen-chymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine 29, 1971-1979. (Pubitemid 40202267)
35. Shi, M., Li, J., Liao, L., et al. (2007). Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 92, 897-904. (Pubitemid 350144236)
36. Son, B.R., Marquez-Curtis, L.A., Kucia, M., et al. (2006). Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24, 1254-1264. (Pubitemid 44464694)
37. Sonabend, A.M., Ulasov, I.V., Tyler, M.A., et al. (2008). Mesenchymal stem cells effectively deliver an oncolytic ade-novirus to intracranial glioma. Stem Cells 26, 831-841.
38. Stoff-Khalili, M.A., Rivera, A.A., Mathis, J.M., et al. (2007). Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res. Treat. 105, 157-167. (Pubitemid 47366887)
39. Studeny, M., Marini, F.C., Champlin, R.E., et al. (2002). Bone marrow-derived mesenchymal stem cells as vehicles for in-terferon-beta delivery into tumors. Cancer Res. 62, 3603-3608. (Pubitemid 34728832)
40. Studeny, M., Marini, F.C., Dembinski, J.L., et al. (2004). Me-senchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 96, 1593-1603. (Pubitemid 39534883)
41. Tse, W.T., Pendleton, J.D., Beyer, W.M., et al. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389-397. (Pubitemid 36222968)
42. Von Luttichau, I., Notohamiprodjo, M., Wechselberger, A., et al. (2005). Human adult CD34(-) progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev. 14, 329-336. (Pubitemid 40885257)
43. Wang, Y., Chen, X., Armstrong, M.A., and Li, G. (2007). Survival of bone marrow-derived mesenchymal stem cells in a xeno-transplantation model. J. Orthop. Res. 25, 926-932. (Pubitemid 47046439)
44. Wells, C.M., and Ridley, A.J. (2005). Analysis of cell migration using the Dunn chemotaxis chamber and time-lapse microscopy. Methods Mol. Biol. 294, 31-41.